CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +1,436 | $10.21 | $15K | 10,473 |
| 2023-01-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +1,296 | $10.21 | $13K | 13,917 |
| 2023-01-31 | Garg Vipin K President and CEO | Grant or award | +1,938 | $10.21 | $20K | 229,713 |
| 2023-01-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award | +1,172 | $10.21 | $12K | 12,010 |
| 2023-01-30 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +302,900 | 302,900 | ||
| 2023-01-30 | Garg Vipin K President and CEO | Grant or award · Restricted Stock Units | +107,100 | 107,100 | ||
| 2023-01-30 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +105,000 | 105,000 | ||
| 2023-01-30 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +37,100 | 37,100 | ||
| 2023-01-30 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Stock Options (option to buy) | +105,000 | 105,000 | ||
| 2023-01-30 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +37,100 | 37,100 | ||
| 2023-01-30 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +105,000 | 105,000 | ||
| 2023-01-30 | Harris Matthew Scott Chief Medical Officer | Grant or award · Restricted Stock Units | +37,100 | 37,100 | ||
| 2023-01-03 | Jordt Raymond M Chief Business Officer | Grant or award · Stock Options (option to buy) | +125,000 | 125,000 | ||
| 2023-01-03 | Jordt Raymond M Chief Business Officer | Grant or award · Restricted Stock Units | +37,500 | 37,500 | ||
| 2022-12-31 | Eisenstadt Richard I Chief Financial Officer | Option exercise | +12,500 | 13,866 | ||
| 2022-12-31 | Eisenstadt Richard I Chief Financial Officer | Shares withheld for taxes | −3,028 | $16.45 | $50K | 10,838 |
| 2022-12-31 | Eisenstadt Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −12,500 | 37,500 | ||
| 2022-12-22 | Pisano Wayne Director | Option exercise | +20,000 | $2.60 | $52K | 28,498 |
| 2022-12-22 | Pisano Wayne Director | Sale | −20,000 | $15.01 | $300K | 8,498 |
| 2022-12-22 | Pisano Wayne Director | Option exercise · Stock Options (option to buy) | −20,000 | 0 |
Page 14 of 29 · 568 trades